Dermatitis due to ingested food

L12_FOODDERMAT

skin disease: Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L27.2 Hospital discharge: ICD-8 — 6925 Cause of death: ICD-10 — L27.2 Cause of death: ICD-8 — 6925 2 out of 7 registries used, show all original rules.	1578
4. Check minimum number of events None	1578
5. Include endpoints None	1578
6. Filter based on genotype QC (FinnGen only)	1578

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L27
Name in latin: Dermatitis ex cibo devorato

NAME	L12_FOODDERMAT
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L272
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	6925
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L272
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	6925
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dermatitis due to ingested food based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	54667	23247	31410
Only index persons	37769	16243	21526
Unadjusted period prevalence (%)
Whole population	0.79	0.67	0.88
Only index persons	0.73	0.60	0.82
Median age at first event (years)
Whole population	1.20	1.28	1.14
Only index persons	1.19	1.31	1.10

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1578	1000	578
Unadjusted period prevalence (%)	0.31	0.34	0.25
Median age at first event (years)	3.35	4.20	1.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1367: Matched controls
13257

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L27.2

ICD-10 Finland

Dermatitis due to ingested food

4503599627370496.0

323.0

1340

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

42.7

323.0

422

137

L20.0

ICD-10 Finland

Besnier prurigo

+∞

323.0

786

C01CA24

ATC

epinephrine; parenteral

19.8

323.0

534

416

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

15.8

261.3

462

414

D07AA02

ATC

hydrocortisone; topical

9.1

249.3

637

1162

E0000UV

ATC

6.9

234.6

940

3207

XQ800

NOMESCO Finland

Prick test

11.6

222.1

458

550

J45.0

ICD-10 Finland

Predominantly allergic asthma

10.4

221.7

492

679

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

8.3

192.5

494

843

D07BA04

ATC

hydrocortisone and antiseptics; topical

8.1

191.2

504

895

E000002

ATC

7.8

188.7

514

956

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

26.8

186.4

265

118

E000001

ATC

6.3

185.4

630

1582

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

178.2

169

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

177.2

168

L20

ICD-10 Finland

Atopic dermatitis

+∞

163.1

155

R06AE07

ATC

cetirizine; oral

4.5

145.0

870

3741

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

5.6

133.8

466

1117

D07AB08

ATC

desonide; topical

8.6

119.1

282

390

R03AC02

ATC

salbutamol; inhalant

3.7

111.4

928

4809

S01GX01

ATC

cromoglicic acid; ophthalmic

4.3

108.1

506

1594

R03BA05

ATC

fluticasone; inhalant

4.2

102.7

498

1606

T78.4

ICD-10 Finland

Allergy, unspecified

8.1

99.0

241

342

D11AH01

ATC

tacrolimus; topical

206.8

95.6

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

5.9

94.6

298

602

R06AX27

ATC

desloratadine; oral

3.4

93.6

662

2866

E000003

ATC

11.6

93.6

183

175

N05BB01

ATC

hydroxyzine; systemic

9.2

92.8

207

253

D07AB02

ATC

hydrocortisone butyrate; topical

4.2

88.4

410

1240

R06AE09

ATC

levocetirizine; oral

4.2

86.1

386

1127

E000006

ATC

8.1

82.9

200

276

R03BA02

ATC

budesonide; inhalant

4.1

82.7

379

1124

XQ802

NOMESCO Finland

Epicutan test

56.7

82.2

J45.9

ICD-10 Finland

Asthma, unspecified

4.0

76.2

358

1075

R03DC03

ATC

montelukast; oral

4.0

75.8

364

1114

H02AB06

ATC

prednisolone; systemic

3.2

75.0

545

2304

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

73.8

D07AC13

ATC

mometasone; topical

4.0

70.6

331

984

R06AX13

ATC

loratadine; oral

3.9

68.2

329

1000

D02AX

ATC

Other emollients and protectives

6.7

67.4

183

297

XQ830

NOMESCO Finland

Exposure to foodstuff

66.7

67.2

D11AX14

ATC

[U] tacrolimus; topical

+∞

64.4

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

30.4

59.1

R03AC03

ATC

terbutaline; inhalant

4.1

56.7

250

691

D07AC01

ATC

betamethasone; topical

3.3

55.1

328

1157

E000007

ATC

5.5

54.6

174

343

505

Kela drug reimbursment

Allergy to cow's milk in infants

21.6

53.7

Z51.6

ICD-10 Finland

Desensitization to allergens

9.7

53.1

112

121

D11AH02

ATC

pimecrolimus; topical

+∞

52.9

J30.3

ICD-10 Finland

Other allergic rhinitis

6.5

52.2

144

236

D07CA01

ATC

hydrocortisone and antibiotics; topical

3.5

51.3

272

873

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

50.8

D11AX15

ATC

[U] pimecrolimus; topical

+∞

48.7

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.9

48.2

217

605

D09AB01

ATC

zinc bandage without supplements; topical

41.8

46.3

R01AD09

ATC

mometasone; nasal

2.3

45.9

615

3440

D02AE01

ATC

carbamide; topical

6.2

45.7

130

221

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

71.7

43.7

A92

ICPC

Allergy/allergic reaction NOS

4.4

42.7

169

416

J45

ICD-10 Finland

Asthma

4.0

42.3

187

510

J45.8

ICD-10 Finland

Mixed asthma

8.3

40.5

116

J45.1

ICD-10 Finland

Nonallergic asthma

3.6

40.0

196

583

R01AD08

ATC

fluticasone; nasal

2.6

39.3

344

1515

XG410

NOMESCO Finland

Flow-volume spirometry

5.4

36.2

114

219

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

34.1

L50.0

ICD-10 Finland

Allergic urticaria

6.3

34.1

153

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.7

32.2

151

430

S87

ICPC

Dermatitis/atopic eczema

5.8

31.9

167

D07CC01

ATC

betamethasone and antibiotics; topical

3.4

31.7

166

516

R06AX22

ATC

ebastine; oral

3.1

31.7

192

663

XG474

NOMESCO Finland

Exhalation nntrogen oxide

5.0

30.8

104

216

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.1

30.7

186

641

R01AD12

ATC

fluticasone furoate; nasal

2.1

30.4

470

2665

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

29.2

30.4

R96

ICPC

Asthma

3.5

30.3

150

446

E000004

ATC

8.0

29.7

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

18.2

27.1

69250

ICD-8 Finland

Other eczema and dermatitis, Due to food

+∞

26.9

D07BC01

ATC

betamethasone and antiseptics; topical

4.8

26.6

196

WQ000

NOMESCO Finland

Hyposensibilisation

8.8

26.3

R01AC01

ATC

cromoglicic acid; nasal

4.5

26.1

218

R03AK07

ATC

formoterol and budesonide; inhalant

2.5

24.8

210

885

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

+∞

23.7

D07AC14

ATC

methylprednisolone aceponate; topical

5.8

23.3

116

R06.2

ICD-10 Finland

Wheezing

3.4

22.7

118

363

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

2.1

22.1

311

1659

D07AB01

ATC

clobetasone; topical

7.2

21.6

J46

ICD-10 Finland

Status asthmaticus

7.3

20.6

S01GX02

ATC

levocabastine; ophthalmic

3.6

20.6

282

H02AB07

ATC

prednisone; oral

3.1

19.2

108

352

D07AD01

ATC

clobetasol; topical

3.2

18.9

102

323

TQW80

NOMESCO Finland

Local dermatologic skincare

8.5

18.8

J01DA01

ATC

[U] cefalexin; systemic

1.7

18.4

580

4026

R06AX26

ATC

fexofenadine; oral

3.5

17.8

246

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

17.6

108

374

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.3

17.6

169

757

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

+∞

17.5

J30.19

ICD-10 Finland

Pollen allergy UNS

3.2

17.5

297

H02AB04

ATC

methylprednisolone; systemic

2.8

17.2

113

409

R01AD05

ATC

budesonide; nasal

3.6

16.6

218

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

62.2

16.5

D11AH05

ATC

dupilumab; topical

+∞

16.5

395

Kela drug reimbursment

Dupilumab

+∞

16.5

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

4.2

16.0

145

R03BC01

ATC

cromoglicic acid; inhalant

7.7

16.0

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.7

15.9

116

448

S01AD03

ATC

aciclovir; ophthalmic

6.5

15.5

L50.9

ICD-10 Finland

Urticaria, unspecified

3.0

15.4

296

S01GX09

ATC

olopatadine; ophthalmic

4.1

15.2

143

506

Kela drug reimbursment

Allergy to cow's milk and hypersensibility to conventional formula in infants

23.0

14.9

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

3.2

14.6

247

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

35.3

14.2

R03BA01

ATC

beclometasone; inhalant

2.6

13.8

104

408

S01GX08

ATC

ketotifen; ophthalmic

3.2

13.7

230

L30.3

ICD-10 Finland

Infective dermatitis

7.2

13.4

R06.0

ICD-10 Finland

Dyspnoea

1.9

13.2

200

1082

R05

ICD-10 Finland

Cough

1.8

12.9

253

1491

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

12.9

203

1114

R02

ICPC

Shortness of breath/dyspnoea

2.1

12.5

142

683

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.2

12.5

128

587

J01FA01

ATC

erythromycin; systemic

2.0

12.5

166

854

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

15.1

12.4

J01DB01

ATC

cefalexin; oral

1.5

12.1

964

8051

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

5.6

11.9

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

7.3

11.9

D07XB05

ATC

dexamethasone, combinations; topical

6.3

11.9

L50.3

ICD-10 Finland

Dermatographic urticaria

5.7

11.8

R03AC12

ATC

salmeterol; inhalant

5.2

11.8

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

11.7

233

1379

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

6.7

11.6

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

63.5

11.5

J01FA10

ATC

azithromycin; systemic

1.5

11.4

945

7901

R06AX12

ATC

terfenadine; oral

4.4

11.1

R03BA08

ATC

ciclesonide; inhalant

2.6

11.0

316

R06AX11

ATC

astemizole; oral

3.7

10.9

127

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

3.1

10.9

190

L50.8

ICD-10 Finland

Other urticaria

4.7

10.9

X57

ICD-10 Finland

Unspecified privation

4.5

10.8

J01FF01

ATC

clindamycin; systemic

1.8

10.8

194

1110

R01AD11

ATC

triamcinolone; nasal

2.7

10.8

283

J01FA09

ATC

clarithromycin; systemic

1.6

10.7

380

2629

W84

ICD-10 Finland

Unspecified threat to breathing

11.7

10.6

R06AX18

ATC

acrivastine; oral

8.1

10.6

R03CC02

ATC

salbutamol; systemic

1.6

10.5

351

2391

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

21.0

10.5

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

10.3

207

1227

134

Kela drug reimbursment

General erythroderma

107.5

10.3

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

107.5

10.3

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

10.2

145

760

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.9

10.2

162

887

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.2

9.9

159

B00.10

ICD-10 Finland

Herpes simplex facialis

8.9

9.8

R03DA04

ATC

theophylline; systemic, rectal

4.3

9.7

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.7

9.6

222

1370

A03FA02

ATC

cisapride; oral, rectal

2.6

9.6

260

XQ820

NOMESCO Finland

Exposure to medicinal substance

13.1

9.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

9.4

810

6678

R03AC13

ATC

formoterol; inhalant

4.5

9.4

UJF32

NOMESCO Finland

Coloscopy

1.9

9.4

131

684

WZC30

NOMESCO Finland

Teaching

2.1

9.3

108

525

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.4

9.3

124

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

9.2

310

2107

R06AE08

ATC

11.2

8.9

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

8.8

231

XQ899

NOMESCO Finland

Other assessment of skin

18.2

8.8

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

4.3

8.8

D07CB01

ATC

triamcinolone and antibiotics; topical

6.4

8.7

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

8.7

268

1780

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.4

8.7

308

J05AB01

ATC

aciclovir; systemic

1.8

8.6

165

963

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

48.8

8.6

A07EB01

ATC

cromoglicic acid; oral

48.8

8.6

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.8

8.5

194

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

4.6

8.5

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

26.9

8.4

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

26.9

8.4

T78.3

ICD-10 Finland

Angioneurotic oedema

6.8

8.3

R01AD01

ATC

beclometasone; nasal

2.1

8.3

461

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

8.3

169

1004

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

8.3

231

1494

D07XC01

ATC

betamethasone, combinations; topical

2.5

8.3

251

L26

ICD-10 Finland

Exfoliative dermatitis

+∞

8.2

S01GX04

ATC

nedocromil; ophthalmic

5.2

8.2

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

8.0

769

6378

49300

ICD-8 Finland

Asthma, bronchiale

11.4

7.9

A02BC01

ATC

omeprazole; systemic

1.7

7.9

176

1073

R01AC02

ATC

levocabastine; nasal

3.6

7.8

R03BB04

ATC

tiotropium bromide; inhalant

3.2

7.7

117

SPAT1312

SPAT

General health counselling

1.4

7.6

606

4846

R03BC03

ATC

nedocromil; inhalant

3.1

7.5

124

SPAT1059

SPAT

Spirometry at the office

3.1

7.5

125

R03AK08

ATC

formoterol and beclometasone; inhalant

3.3

7.2

101

SPAT1058

SPAT

PEF monitoring instruction

2.0

7.2

411

XQ801

NOMESCO Finland

Intracutantest

19.5

7.0

A02BA02

ATC

ranitidine; systemic

2.2

6.9

318

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

16.3

6.6

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

7.0

6.5

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.9

6.5

131

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

4.8

6.5

XQ848

NOMESCO Finland

Dermatological photography

4.8

6.5

R04

ICPC

Breathing problem other

2.8

6.4

139

J04.0

ICD-10 Finland

Acute laryngitis

1.8

6.4

109

613

EMB30

NOMESCO Finland

Adenotomy

1.5

6.3

210

1413

E0001A1

ATC

2.5

6.3

194

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

6.3

264

L27.9

ICD-10 Finland

Dermatitis due to unspecified substance taken internally

+∞

6.2

H13.1*B00.5

ICD-10 Finland

Herpesviral conjunctivitis

+∞

6.2

L27.8

ICD-10 Finland

Dermatitis due to other substances taken internally

+∞

6.2

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

10.7

6.2

Z27.4

ICD-10 Finland

Need for immunization against measles-mumps-rubella [MMR]

17.6

6.2

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

17.6

6.2

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

6.1

468

3685

J35.2

ICD-10 Finland

Hypertrophy of adenoids

1.6

6.1

145

899

J01FA06

ATC

roxithromycin; oral

1.5

6.1

214

1459

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

6.0

292

2122

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

6.0

290

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

199

39.04

310.73

1.4

1.1

u/ml

21.7

4.7

1.85

172

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

155

59.04

266.99

1.2

1.1

u/ml

6.3

4.0

0.25

139

(3011897) Casein IgE Ab [Units/volume] in Serum

169

37.10

261.04

2.0

1.1

u/ml

15.6

0.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

175

19.63

213.81

1.3

1.1

u/ml

38.4

4.7

1.47

151

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

115

59.67

198.79

1.2

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

107

73.65

191.56

2.1

1.1

u/ml

15.2

0.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

175

168

11.16

154.97

1.8

1.0

u/ml

20.8

0.8

2.33

149

(3020874) Milk IgE Ab [Units/volume] in Serum

178

10.73

153.20

1.8

1.1

u/ml

10.0

0.8

4.28

145

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

31.00

138.74

1.1

1.0

u/ml

9.7

0.5

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

29.69

135.39

1.1

1.0

u/ml

2.2

0.0

1.56

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

42.67

129.04

1.1

1.0

u/ml

3.0

4.0

0.10

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

35.24

122.79

1.1

1.0

u/ml

0.5

0.0

2.64

(3016031) Almond IgE Ab [Units/volume] in Serum

36.82

113.44

1.1

u/ml

1.9

0.6

1.45

(3010726) Horse dander IgE Ab [Units/volume] in Serum

264

572

5.14

111.10

1.2

1.1

u/ml

5.2

2.1

2.13

105

174

(3003888) Timothy IgE Ab [Units/volume] in Serum

262

580

5.02

107.35

1.3

1.1

u/ml

7.0

7.9

0.29

219

357

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

26.47

106.61

1.1

1.0

u/ml

0.6

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

347

972

4.13

105.21

1.8

1.3

u/ml

1344.4

189.4

6.27

337

899

(3015076) Soybean IgE Ab [Units/volume] in Serum

131

146

9.34

103.48

1.3

1.0

u/ml

1.3

0.4

1.46

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

272

650

4.66

101.30

1.3

1.1

u/ml

2.9

3.5

0.25

210

335

(3008401) Mugwort IgE Ab [Units/volume] in Serum

251

564

4.91

100.76

1.3

1.1

u/ml

2.1

1.0

1.35

203

316

(3019420) Tryptase [Mass/volume] in Serum or Plasma

14.74

82.17

1.6

1.2

ug/l

8.3

5.2

0.48

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

33.63

81.85

1.0

u/ml

2.7

0.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

22.60

80.77

1.1

1.0

u/ml

15.7

2.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

11.48

78.93

1.2

1.3

u/ml

1.4

0.6

0.50

(3014133) Dog dander IgE Ab [Units/volume] in Serum

174

428

4.28

61.30

1.1

u/ml

11.9

3.0

4.81

118

201

(3023430) Cat dander IgE Ab [Units/volume] in Serum

153

395

4.02

50.27

1.1

u/ml

12.8

8.2

1.17

111

198

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

131

345

3.90

41.73

1.1

1.0

u/ml

1.3

0.2

1.86

(3013115) Eosinophils [#/volume] in Blood

886

6150

1.89

32.47

7.1

8.0

e9/l

0.3

0.2

22.46

791

5346

(3006315) Basophils [#/volume] in Blood

858

5967

1.85

30.48

7.0

7.3

e9/l

0.0

0.64

756

5077

(3001604) Monocytes [#/volume] in Blood

856

5954

1.84

30.34

7.0

7.4

e9/l

0.6

0.5

1.58

756

5071

(3006504) Eosinophils/100 leukocytes in Blood

827

5725

1.83

29.42

6.9

7.5

4.3

2.8

25.17

781

5401

(3019198) Lymphocytes [#/volume] in Blood

883

6244

1.83

29.20

7.0

7.2

e9/l

2.3

2.2

1.36

801

5463

(3019069) Monocytes/100 leukocytes in Blood

829

5773

1.81

28.62

7.0

7.6

8.0

8.1

0.63

788

5463

(4010399)

134

455

3.01

28.50

1.5

1.3

—

(3022096) Basophils/100 leukocytes in Blood

800

5536

1.80

27.98

6.9

7.6

0.6

0.03

759

5230

(42870588) Differential panel, method unspecified - Blood

646

4199

1.82

27.82

6.3

8.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

858

6094

1.78

27.15

6.9

7.2

33.5

0.00

821

5768

(3018010) Neutrophils/100 leukocytes in Blood

844

5974

1.78

26.94

6.7

7.1

50.8

52.2

2.42

808

5675

(3013650) Neutrophils [#/volume] in Blood by Automated count

918

6717

1.76

25.54

7.8

9.3

e9/l

3.7

0.26

809

5711

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

125

4.68

24.88

3.5

2.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

5.50

21.93

1.0

u/ml

17.5

4.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

12.63

21.92

1.1

u/ml

0.0

—

(3000492) Spirometry study

180

865

2.13

18.20

1.5

1.3

—

(3021589) Normoblasts [#/volume] in Blood

750

5713

1.51

13.88

8.5

9.0

e9/l

0.0

0.78

606

4524

(3013707) Erythrocyte sedimentation rate by Westergren method

922

7372

1.49

13.16

4.1

3.6

mm/h

8.0

7.4

0.86

862

6832

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

7.30

12.13

1.2

1.0

—

(40758558) Short blood count panel - Blood

446

3124

1.52

11.88

5.9

8.1

—

(3048689) Calprotectin [Mass/mass] in Stool

325

2157

1.57

10.93

3.3

2.9

ug/g

145.4

104.1

0.77

258

1685

(3001488) Cow milk IgE Ab [Units/volume] in Serum

27.18

10.53

1.0

u/ml

0.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

200

1203

1.69

9.96

1.9

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

369

2568

1.50

9.87

5.3

4.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

514

3843

1.43

9.41

1.7

1.5

g/l

1.7

0.01

302

2165

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

552

4189

1.41

9.26

3.0

2.9

nmol/l

69.1

68.1

0.34

520

3943

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

549

4256

1.37

7.80

1.6

u/ml

1.0

2.4

3.58

118

921

(40768797) Stomach Pathology biopsy report

138

816

1.69

7.31

1.5

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

106

603

1.74

6.47

1.4

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

119

701

1.69

6.41

4.5

4.0

0.3

0.5

0.50

144

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

136

2.59

6.41

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1317

11854

1.43

6.31

11.2

9.2

mg/l

20.0

21.4

0.81

970

8356

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1039

9015

1.32

6.29

3.9

3.5

pmol/l

14.3

14.4

0.43

929

8094

(3005719) IgG [Mass/volume] in Serum or Plasma

165

1059

1.56

6.29

3.0

3.2

g/l

10.2

9.7

0.99

154

1006

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

207

1406

1.48

6.05

1.3

1.2

iu/ml

13.7

27.4

2.17

326

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

182

1206

1.51

6.00

1.6

1.5

pmol/l

437.2

12687000.9

0.80

155

1072

(3017181) Myelocytes/100 leukocytes in Blood

123

748

1.63

5.88

4.6

4.5

0.6

0.7

0.11

202

(44813793)

154

2.41

5.87

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

104

607

1.70

5.82

1.3

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

173

1147

1.51

5.69

1.3

titre

30.8

372.0

—

(3037522) Nuclear Ab [Titer] in Serum

207

1425

1.46

5.65

1.6

1.5

titre

466.4

512.9

0.14

230

(3025159) Blasts/100 leukocytes in Blood

115

695

1.64

5.64

4.8

4.6

0.0

0.20

161

(3021440) Promyelocytes/100 leukocytes in Blood

117

711

1.63

5.62

4.7

4.6

0.1

0.05

185

(3002385) Erythrocyte distribution width [Ratio]

1228

10983

1.35

5.61

12.7

12.5

13.1

13.2

0.11

1202

10749

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

208

2.16

5.54

1.2

1.1

iu/ml

4.6

6.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.86

5.45

1.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

178

1199

1.48

5.42

2.4

2.3

nmol/l

321.1

367.8

3.05

167

1129

(3003740) Influenza virus B Ag [Presence] in Specimen

351

1.88

5.40

1.2

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

230

2.09

5.38

3.7

3.6

51.3

52.7

0.26

230

(3002523) Influenza virus A Ag [Presence] in Specimen

352

1.87

5.36

1.2

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

225

2.09

5.29

3.2

3.3

e9/l

3.6

0.05

225

(3000494) Fungus identified in Specimen by Culture

142

927

1.52

5.03

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

546

4442

1.28

5.00

9.0

9.2

mmol/l

1.2

0.57

483

3936

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

12.90

4.97

1.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

509

4111

1.28

4.93

11.0

9.8

mmol/l

1.2

0.88

477

3861

(40768443) Skin Pathology biopsy report

219

2.05

4.89

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

226

2.03

4.87

1.4

1.3

ug/g

370.5

359.3

0.12

104

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

400

3149

1.30

4.68

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

350

2707

1.32

4.66

3.6

3.1

estimate

0.0

0.41

140

1010

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

402

1.73

4.49

1.8

1.6

iu/ml

0.4

0.1

0.40

(3024139) IgG subclass 3 [Mass/volume] in Serum

151

2.19

4.34

1.3

1.5

g/l

0.3

0.4

1.20

124

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

189

1344

1.40

4.32

1.3

1.2

u/ml

8.1

7.9

0.01

476

(3009871) Measles virus Ab [Titer] in Serum

4.26

4.32

1.7

2.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

321

1.80

4.28

1.1

1.2

—

(4062490)

152

2.18

4.28

1.3

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

424

1.69

4.23

1.1

au/ml

18.8

13.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

206

1.99

4.17

1.3

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

262

1977

1.33

4.12

2.6

2.2

ng/l

43.9

34.6

0.10

728

(3019309) Folate [Moles/volume] in Red Blood Cells

128

854

1.48

4.12

1.7

1.5

nmol/l

1145.8

1126.1

0.09

667

(40761536) Microorganisms panel - Urine sediment

143

976

1.45

4.10

3.7

3.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

339

2656

1.29

4.06

3.1

2.7

mg/l

2.4

2.6

1.32

294

2345

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

332

2605

1.29

3.92

1.8

1.5

pmol/l

93.1

97.4

1.02

189

1409

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

771

6661

1.23

3.85

6.7

5.6

u/l

92.4

93.3

0.14

724

6233

(3028026) IgM [Mass/volume] in Serum or Plasma

123

826

1.47

3.85

2.1

1.9

g/l

1.2

1.1

0.15

116

783

(3023368) Bacteria identified in Blood by Culture

241

1816

1.33

3.83

4.6

4.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.23

3.80

1.0

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1136

10230

1.25

3.79

4.5

4.0

mu/l

2.0

0.02

1067

9645

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

2.84

3.74

1.1

u/ml

23.7

17.8

—

(3007461) Platelets [#/volume] in Blood

1471

13736

1.49

3.68

15.6

13.6

e9/l

271.5

265.6

2.92

1422

13217

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

244

1852

1.32

3.68

2.3

2.4

u/l

201.2

274.4

0.65

236

1776

(3000963) Hemoglobin [Mass/volume] in Blood

1474

13770

1.50

3.68

15.7

13.7

g/l

135.4

135.1

0.42

1455

13542

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

296

1.75

3.57

1.4

2.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

205

1.90

3.54

1.1

—

(3017732) Neutrophils [#/volume] in Blood

650

1.50

3.48

2.6

1.9

e9/l

4.3

4.2

0.12

556

(3024731) MCV [Entitic volume]

1471

13755

1.47

3.44

15.4

13.4

87.9

87.6

1.62

1451

13529

(3035941) MCH [Entitic mass]

1471

13757

1.46

3.41

15.4

13.4

29.5

29.4

1.84

1452

13532

(3041672) Baker's yeast Ab [Presence] in Serum

3.15

3.40

1.1

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

1471

13761

1.46

3.36

15.5

13.5

e12/l

4.6

0.73

1417

13206

(3024561) Albumin [Mass/volume] in Serum or Plasma

395

3222

1.24

3.32

6.9

6.3

g/l

38.1

37.9

0.34

375

3033

(3042631) Mycobacterium sp identified in Specimen

3.43

3.28

5.0

2.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.43

3.28

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

219

1.82

3.23

1.6

1.7

g/l

1.4

0.8

1.01

184

(42870560) Thyrotropin [Units/volume] in Cord blood

269

1.74

3.23

1.0

mu/l

8.7

8.8

0.03

229

(3035933) Granulocytes/100 leukocytes in Blood

151

2.00

3.20

1.3

1.8

—

(3010813) Leukocytes [#/volume] in Blood

1471

13775

1.44

3.19

15.5

13.5

e9/l

6.9

6.8

1.05

1417

13228

(3022145) Colonoscopy Study observation

109

746

1.44

3.13

1.4

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

208

1.83

3.10

1.0

kpa

3.4

3.2

0.37

172

(3037467) Urinalysis macro (dipstick) panel - Urine

828

7297

1.20

3.10

4.2

3.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

120

2.11

3.09

1.8

1.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

183

1373

1.32

3.01

6.5

9.2

mmol/l

0.8

0.31

172

1324

(3004616) Nuclear Ab [Presence] in Serum

2.50

2.98

1.3

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.77

2.98

1.7

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

607

5219

1.20

2.94

4.6

4.3

estimate

0.0

0.50

144

1045

(3006598) pH of Arterial cord blood

212

1.79

2.93

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

212

1.79

2.93

1.0

mmol/l

-2.5

-1.2

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

212

1.79

2.93

1.0

kpa

7.3

7.2

0.22

175

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

337

1.62

2.92

1.1

—

(3032080) INR in Blood by Coagulation assay

302

2425

1.25

2.90

5.8

3.9

inr

1.1

0.55

132

818

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

155

1142

1.34

2.89

1.3

iu/ml

145.2

130.8

0.14

372

(3009261) Glucose [Presence] in Urine by Test strip

611

5264

1.19

2.88

3.4

3.1

estimate

0.0

0.00

138

1024

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

3.13

2.87

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

112

2.08

2.80

1.0

—

(3012501) Base excess in Blood by calculation

194

1.81

2.79

3.3

4.5

mmol/l

1.7

2.0

0.31

(3048929) Epstein Barr virus Ab [Presence] in Serum

178

1345

1.31

2.79

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

604

5213

1.19

2.76

3.4

3.0

estimate

0.0

0.00

135

992

(3019550) Sodium [Moles/volume] in Serum or Plasma

1154

10538

1.21

2.72

11.5

9.7

mmol/l

139.5

0.09

1114

10162

(3018418) pH of Serum or Plasma

276

2210

1.25

2.72

3.4

3.6

7.4

0.12

404

(3013512) EKG study

202

1559

1.28

2.70

2.6

2.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

4.30

2.70

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

414

1.53

2.70

4.3

4.1

nmol/l

26.4

25.0

0.26

405

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

173

1313

1.30

2.64

1.1

—

(3023419) Bacteria identified in Sputum by Culture

2.96

2.63

8.4

6.1

—

(3002582) Erythrocytes [#/volume] in Urine

386

3212

1.21

2.62

3.8

3.5

e6/l

44.8

81.5

0.49

293

2373

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

170

1.83

2.61

2.0

2.8

e6/l

1029.3

761.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1154

10557

1.20

2.57

11.5

9.7

mmol/l

3.9

0.38

1112

10130

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

459

3888

1.19

2.56

3.4

2.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

507

1.47

2.55

2.2

1.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

312

1.59

2.53

1.6

1.8

—

(36660697) Celiac disease serology panel - Serum

212

1661

1.26

2.52

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

791

7021

1.17

2.51

4.3

3.7

e6/l

1916.4

795.4

0.30

(3000850) Epithelial cells [#/volume] in Urine

263

2121

1.23

2.43

3.2

2.8

e6/l

8.9

8.6

0.08

229

1857

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

474

4045

1.18

2.41

5.9

6.1

umol/l

17.6

15.3

0.66

442

3703

(3013826) Glucose [Moles/volume] in Serum or Plasma

635

5551

1.17

2.41

6.6

5.7

mmol/l

6.1

6.0

0.41

579

5034

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

103

734

1.38

2.41

2.3

2.2

au/ml

4.8

13.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

111

801

1.36

2.40

1.9

2.1

nmol/l

10.7

9.7

0.42

691

(3027945) Reticulocytes/100 erythrocytes in Blood

142

1067

1.31

2.35

4.4

5.7

1.4

0.20

134

998

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.15

2.33

1.8

1.2

—

(3026782) Osmolality of Urine

252

2033

1.23

2.32

3.1

2.7

mosm/kgh2o

580.3

592.6

0.31

223

1750

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

626

5480

1.17

2.31

2.0

1.9

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

417

3532

1.19

2.30

4.0

3.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

1318

12248

1.23

2.30

11.7

11.3

40.0

0.09

1139

10545

(3026493) Urate [Moles/volume] in Serum or Plasma

174

1349

1.27

2.27

2.5

3.5

umol/l

4512.7

3396.9

0.14

149

1250

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

103

1.98

2.20

4.6

5.5

mg/l

8.1

9.1

0.35

(3021960) Folate [Moles/volume] in Serum or Plasma

189

1488

1.25

2.18

1.6

1.4

nmol/l

19.8

19.0

0.36

163

1322

(1001926) Buprenorphine [Presence] in Urine by Screen method

117

1449

0.76

2.17

1.6

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

218

1.65

2.17

3.4

2.5

mg/l

21.9

28.2

0.71

141

(3027570) Oxalate [Moles/time] in 24 hour Urine

5.36

2.15

1.2

1.1

umol/24h

251.2

217.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

105

767

1.34

2.13

2.8

5.8

u/l

226.2

255.6

2.31

100

742

(3001122) Ferritin [Mass/volume] in Serum or Plasma

696

6173

1.15

2.11

3.2

3.0

ug/l

54.7

59.4

0.41

650

5831

(3011412) CD3 cells [#/volume] in Blood

235

1.61

2.10

2.4

3.2

e9/l

1.5

1.4

0.14

155

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

297

2466

1.20

2.04

2.7

2.4

u/l

61.8

54.4

0.72

272

2265

(3030467) Casts [#/volume] in Urine by Automated count

351

2962

1.18

2.01

3.8

3.3

e6/l

0.2

0.3

0.65

262

2159

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

386

3285

1.17

2.00

3.5

3.7

u/l

31.7

30.9

0.09

372

3142

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.25

1.89

1.3

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.25

1.89

1.3

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.25

1.89

1.3

1.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

206

1665

1.22

1.88

7.9

9.9

mmol/l

1.2

1.3

1.17

196

1578

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.42

1.86

2.4

1.4

—

(36304419) Bacteria [Presence] in Urine

355

3019

1.17

1.85

3.7

3.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.96

1.78

1.3

1.1

—

(3020650) Glucose [Presence] in Urine

2.76

1.78

1.1

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

910

8282

1.14

1.77

8.2

6.4

ml/min/173m2

105.7

106.7

0.61

686

5936

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

714

1.31

1.76

3.0

3.4

pmol/l

4.8

5.0

0.70

652

(3009214) Lutropin [Units/volume] in Serum or Plasma

113

862

1.28

1.73

2.0

1.9

u/l

6.0

6.8

0.93

629

(1616796) Gas panel - Central venous blood

217

1.57

1.72

3.1

3.9

—

(40767503) Oxygen content in Capillary blood by calculation

164

1.66

1.72

2.5

2.8

17.5

17.4

0.03

(3037756) Immunofixation for Serum or Plasma

2.67

1.71

1.5

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

117

899

1.27

1.69

2.0

1.8

iu/l

9.4

11.1

0.42

670

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

2.13

1.69

1.2

1.1

u/l

127.4

210.7

—

(3023520) Reticulocytes [#/volume] in Blood

728

1.30

1.68

2.9

4.1

e9/l

61.9

65.6

0.55

473

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

231

1910

1.19

1.68

1.6

1.7

mmol/l

1.2

1.3

0.23

199

1721

(3042111) Morphology [Interpretation] in Bone marrow Narrative

2.05

1.66

1.6

2.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

636

1.32

1.66

3.1

2.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

165

1323

1.22

1.65

1.8

2.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.36

1.62

1.6

1.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

129

0.37

1.62

1.0

2.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

276

1.48

1.61

2.1

1.9

iu/l

6.0

4.9

0.15

(3026008) Bacteria identified in Urine by Culture

339

2913

1.15

1.54

2.8

2.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

215

2392

0.84

1.52

2.7

2.6

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

2.90

1.51

1.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

171

1393

1.20

1.48

2.6

2.7

umol/l

13.6

14.4

0.72

163

1322

(3041096) Erythrocytes [Presence] in Urine by Automated

344

2969

1.15

1.47

2.9

2.6

—

(3003694) ABO and Rh group [Type] in Blood

405

4285

0.88

1.45

1.8

1.7

—

(3010503) CD19 cells [#/volume] in Blood

2.13

1.44

2.3

2.6

e9/l

0.2

0.25

(3018095) Leukocytes [#/volume] in Urine

450

3960

1.13

1.43

4.4

4.0

e6/l

87.6

64.3

0.28

309

2551

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

212

1.51

1.43

2.7

3.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

221

1.49

1.40

2.6

3.2

8.9

10.1

0.39

187

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.86

1.39

1.1

miu/ml

1847.1

1484.1

0.65

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.23

1.38

1.2

—

(4306422)

152

1.59

1.38

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

901

8267

1.12

1.37

2.9

2.5

mmol/l

5.4

0.04

829

7655

(3027944) Amphetamines [Presence] in Urine

161

1819

0.84

1.37

1.5

1.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

327

1.40

1.37

1.1

—

(3015736) pH of Urine

471

4167

1.13

1.37

3.1

2.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

303

1.41

1.36

2.1

2.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.00

1.36

1.2

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

277

2993

0.87

1.35

2.7

2.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

153

1.58

1.34

1.2

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

108

1.70

1.34

1.5

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.52

1.30

1.5

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.52

1.30

1.0

1.4

—

(3009343) pH of Capillary blood

172

1421

1.19

1.30

9.2

9.9

7.4

—

(3011288) Drugs identified in Urine by Screen method

110

1281

0.81

1.29

1.5

2.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

303

2617

1.14

1.28

2.8

2.7

mmol/l

2.4

0.18

274

2390

(3012516) Albumin [Mass/volume] in Urine

141

1145

1.20

1.28

3.6

3.8

mg/l

121.9

249.0

0.65

877

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

688

1.26

1.28

3.5

3.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

171

1414

1.18

1.28

9.2

9.9

mmol/l

0.5

1.0

1.22

125

1026

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

172

1423

1.18

1.28

9.2

9.9

kpa

5.1

5.0

0.03

167

1373

(3000764) Benzodiazepines [Presence] in Urine

164

1836

0.84

1.27

1.5

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

110

1.67

1.27

1.6

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

437

4568

0.89

1.27

4.3

4.0

—

(3016879) Cocaine [Presence] in Urine

151

1702

0.84

1.27

1.5

1.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

143

1165

1.20

1.26

4.3

4.5

mg/mmol

17.9

12.7

0.28

877

(3028300) Cannabinoids [Presence] in Urine

166

1855

0.85

1.26

1.5

1.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

756

6893

1.11

1.26

3.6

3.2

mmol/mol

36.0

36.1

0.17

703

6517

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.41

1.24

1.5

1.3

ug/l

11.3

10.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.02

1.24

2.1

1.5

—

(3027008) Opiates [Presence] in Urine

166

1852

0.85

1.24

1.5

1.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

502

1.30

1.24

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

188

1.49

1.23

1.1

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

334

1.37

1.23

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.68

1.23

1.0

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.21

1.23

1.0

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

2.21

1.23

4.8

3.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

185

1546

1.17

1.23

2.7

2.3

u/l

5176.0

6980.6

0.44

510

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

530

1.28

1.20

3.2

3.8

mmol/l

1.2

0.23

460

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

121

976

1.21

1.19

2.2

mmol/l

2.4

0.16

101

842

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

116

932

1.21

1.19

1.7

2.0

—

(3042936) Bacteria identified in Isolate by Culture

130

1057

1.20

1.18

2.2

1.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

143

1.56

1.18

3.3

4.6

—

(3020891) Body temperature

206

1.46

1.18

10.6

5.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

321

1.36

1.17

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

106

1.64

1.15

1.0

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

474

1.29

1.14

1.1

u/ml

3.4

3.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

578

1.26

1.13

1.7

1.8

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

315

1.36

1.12

1.3

1.5

nmol/l

39.8

37.0

0.33

310

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

107

1.63

1.11

1.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

107

1.63

1.11

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

107

1.63

1.11

1.0

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

140

1154

1.18

1.11

2.8

21.3

23.0

0.72

129

1055

(3021879) Hepatitis B virus core Ab [Presence] in Serum

150

1244

1.18

1.11

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1309

12328

1.14

1.11

4.2

3.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

1.90

1.11

1.6

1.4

nmol/l

0.8

1.2

0.92

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.41

1.10

1.0

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

108

1.61

1.08

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

108

1.61

1.08

1.0

1.2

—

(3045424) Erythrocytes [Presence] in Urine

139

1.53

1.07

1.0

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

152

1269

1.17

1.04

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

328

1.33

1.04

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.30

1.04

1.2

1.3

u/l

14.8

14.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.75

1.03

1.2

1.0

u/l

0.9

1.0

—

(3028433) Virus identified in Specimen by Culture

1.83

1.01

1.1

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

355

1.31

1.01

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1.89

1.01

1.6

1.8

55.6

52.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.89

1.01

4.6

2.9

—

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.89

1.01

1.2

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

291

2549

1.12

1.00

3.5

3.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

103

1.60

0.99

1.4

1.3

mmol/l

1.6

0.09

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.99

0.99

5.4

8.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

116

952

1.19

0.99

1.9

2.0

—

(3019225) pH of Specimen

520

1.25

0.98

2.4

3.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

477

1.26

0.98

1.7

1.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

417

1.28

0.97

1.4

1.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.97

0.0

1.1

—

(3000991) Gas panel - Venous blood

167

1414

1.15

0.97

12.8

10.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

120

990

1.18

0.97

1.7

1.6

mu/l

372.8

333.0

0.42

115

885

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

105

1188

0.84

0.96

2.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.95

0.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.95

0.0

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

144

1.48

0.94

1.1

1.0

g/l

1.4

0.16

133

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.23

0.93

1.8

2.6

—

(3021788) Differential panel - Synovial fluid

1.61

0.92

1.4

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

207

1787

1.13

0.91

3.3

3.1

e6/l

4.0

3.8

0.12

103

955

(3022313) Gas panel - Capillary blood

145

1223

1.16

0.90

9.5

9.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

154

1.44

0.89

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

278

1.32

0.88

1.5

1.6

—

(3025130) Human papilloma virus identified in Specimen

150

0.58

0.88

1.2

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

112

928

1.17

0.87

1.7

1.9

—

(3003338) MCHC [Mass/volume]

1229

11577

1.10

0.87

12.7

12.0

g/l

334.9

334.4

1.12

1220

11457

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

107

1.54

0.87

3.2

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.00

0.86

1.3

2.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.61

0.86

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

287

0.70

0.85

3.2

3.6

ug/l

3.8

4.9

0.29

193

(40768804) Tissue Pathology biopsy report

331

2949

1.10

0.85

1.7

—

(40761511) CBC panel - Blood by Automated count

1302

12307

1.11

0.84

9.5

7.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

124

1.48

0.83

1.3

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.75

0.83

1.1

1.7

u/l

5.6

7.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

143

1215

1.15

0.82

10.0

10.1

kpa

9.7

0.14

137

1179

(3019832) Treponema pallidum Ab [Presence] in Serum

366

3283

1.10

0.81

1.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.72

0.81

1.3

1.0

—

3.3

—

(3012544) pH of Venous blood

182

1573

1.13

0.81

7.6

9.1

—

7.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

182

1.38

0.81

1.2

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

649

1.20

0.81

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

205

1785

1.12

0.81

3.4

3.0

e6/l

1.6

0.9

0.98

105

951

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

446

0.77

0.79

1.4

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

150

1.42

0.79

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

118

1.47

0.78

1.4

2.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.81

0.78

1.3

1.2

u/l

172.3

193.7

—

(3021901) Oxygen saturation in Capillary blood

167

1.39

0.78

3.2

7.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

135

1.43

0.76

2.7

3.8

1.3

1.0

0.28

108

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

127

1.45

0.76

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

193

1.35

0.75

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

210

1.34

0.75

2.4

3.6

17.2

17.7

0.05

205

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.10

0.74

3.4

2.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

146

1252

1.14

0.74

2.7

g/l

2.5

2.6

1.44

140

1179

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

136

1.42

0.74

2.0

1.6

—

(3025941) Bacteria identified in Stool by Culture

647

1.19

0.73

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

470

1.22

0.73

1.7

1.9

u/ml

110.0

96.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.61

0.72

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.61

0.72

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.61

0.72

1.0

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

299

0.74

0.72

1.3

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

604

1.19

0.72

1.1

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

162

1.37

0.71

2.6

1.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

289

1.27

0.71

1.1

u/ml

1.5

3.8

0.86

103

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.73

0.70

2.3

1.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

221

1.31

0.70

1.4

1.5

—

(3002032) Base excess in Venous blood by calculation

179

1562

1.12

0.70

7.6

9.0

mmol/l

1.2

1.3

0.19

143

1233

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

226

1999

1.10

0.69

2.1

3.1

mg/l

2.1

1.0

0.72

148

1378

(3044290) Cell count panel - Cerebral spinal fluid

317

1.25

0.67

1.8

3.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

627

1.18

0.67

1.8

1.7

u/ml

149.9

187.1

0.74

334

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.59

0.66

1.8

2.6

u/ml

556.7

1029.3

1.61

(3020630) Protein [Mass/volume] in Serum or Plasma

371

1.23

0.65

2.7

3.1

g/l

67.2

65.9

0.50

354

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

224

1.30

0.65

1.2

—

33.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

665

1.17

0.65

3.1

2.4

30.5

32.7

1.31

501

(3039162) Centromere protein B Ab [Units/volume] in Serum

132

1.39

0.64

1.2

1.3

—

29.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.57

0.64

4.0

8.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

242

1.28

0.63

1.3

1.2

iu/ml

329.5

195.6

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1.56

0.63

2.5

1.5

31.4

32.5

0.30

(3026389) Candida sp identified in Specimen by Organism specific culture

166

1.34

0.63

1.6

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

115

1242

0.88

0.62

2.8

3.5

ng/l

657.5

959.3

0.42

622

(3003396) Base excess in Arterial blood by calculation

569

1.18

0.62

22.3

10.6

mmol/l

0.0

-0.0

0.02

434

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

226

1.28

0.62

2.6

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.60

0.0

1.7

—

(3045414) Leukocytes [Presence] in Urine

428

1.20

0.60

1.3

1.7

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.60

0.0

1.1

—

(3019060) Gas panel - Arterial blood

227

1.28

0.60

20.3

4.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.45

0.60

1.3

1.1

—

(3045142) Bone marrow Pathology biopsy report

1.45

0.60

1.4

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

185

1.31

0.59

1.6

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

228

1.27

0.58

1.0

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

100

854

1.14

0.58

2.3

u/l

31.9

29.4

0.39

704

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.70

0.57

1.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.44

0.57

1.2

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.52

0.57

2.3

2.2

43.5

39.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.57

0.56

1.4

1.2

—

(40761535) Cells panel - Urine sediment

548

1.17

0.56

4.3

3.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

335

1.21

0.55

1.5

1.6

nmol/l

0.2

0.3

0.85

266

(3016228) CD19 cells/100 cells in Blood

1.61

0.55

3.0

2.4

12.5

12.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.61

0.55

2.8

2.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.42

0.54

1.2

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.42

0.54

1.2

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

145

1.33

0.54

1.5

mmol/l

9.3

11.0

—

(3051651) Icteric interference index of Serum or Plasma

121

0.63

0.54

1.9

5.0

—

(1002224) Polysomnography panel

257

1.24

0.54

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1067

0.89

0.54

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.53

0.54

2.6

2.4

—

188.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

372

1.20

0.53

20.9

13.8

0.7

0.86

372

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

431

0.82

0.53

1.6

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

368

0.81

0.53

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

525

4855

1.06

0.53

2.3

2.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

444

1.18

0.52

2.2

2.6

ml/min/173m2

92.3

89.3

0.19

140

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1215

11522

1.07

0.51

8.6

7.5

u/l

28.0

25.5

0.84

1182

11097

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

356

1.20

0.51

1.5

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

512

0.84

0.51

1.4

1.5

mg/l

4.6

3.6

0.35

343

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.48

0.51

1.5

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.48

0.51

1.5

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.48

0.51

1.5

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.48

0.51

1.5

2.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

155

1371

1.10

0.50

7.2

8.9

mmol/l

23.7

0.11

146

1325

(3017143) Hepatitis C virus Ab [Presence] in Serum

242

2184

1.08

0.50

1.7

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

199

1.26

0.50

3.1

2.6

—

(40768441) Liver Pathology biopsy report

103

0.65

0.49

1.7

—

(4094501)

105

0.64

0.48

1.0

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

283

2573

1.07

0.48

3.3

3.8

mmol/l

9.4

8.8

0.81

252

2360

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

702

1.13

0.48

7.0

7.1

ng/l

58.1

56.2

0.11

670

(3043238) Trisomy 21 risk [Likelihood] in Fetus

601

0.86

0.48

1.6

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.38

0.47

1.2

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.38

0.47

1.2

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

440

1.17

0.47

3.6

3.8

umol/l

5.8

8.7

1.11

361

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

227

1.23

0.47

1.6

2.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

589

0.86

0.47

1.6

1.5

—

(21494755) Public health laboratory ask at order entry panel

120

1266

0.91

0.46

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

159

0.72

0.46

5.8

7.0

g/mol

32.3

86.3

1.89

144

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

1.44

0.46

1.0

1.2

—

0.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

623

1.13

0.45

1.9

1.5

—

(3022621) pH of Urine by Test strip

623

1.13

0.45

2.0

2.3

—

(3003181) Sodium [Moles/volume] in Urine

150

1.29

0.45

5.6

3.6

mmol/l

79.3

83.7

0.12

134

(3005033) Fetal Nuchal fold Thickness US

587

0.87

0.45

1.6

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.41

0.45

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.41

0.45

2.6

2.1

—

(4027681)

116

1.33

0.45

1.2

—

(3044889) 12 lead EKG panel

552

5136

1.05

0.45

2.5

2.3

—

(3052851) Hemolysis interference index of Serum or Plasma

317

1.19

0.45

1.8

3.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.38

0.44

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.38

0.44

1.0

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

1.38

0.44

2.6

2.1

mmol/l

108.0

106.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.38

0.44

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.38

0.44

1.0

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

124

0.70

0.43

32.2

32.1

ug/l

126.4

159.9

—

114

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

100

1.35

0.43

1.2

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1.61

0.43

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

310

1.19

0.42

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

310

1.19

0.42

1.6

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.44

0.42

1.0

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.43

0.42

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

109

1.33

0.42

1.0

1.2

—

(3017509) Phencyclidine [Presence] in Urine

1.56

0.42

1.0

2.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

222

1.22

0.42

1.6

2.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.38

0.41

1.1

—

(3008898) HLA-B27 [Presence]

610

1.13

0.41

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.40

0.40

1.1

iu/ml

211.5

232.2

0.10

(3027273) Bicarbonate [Moles/volume] in Venous blood

312

1.18

0.40

7.0

5.8

mmol/l

24.3

24.4

0.06

299

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.35

0.40

1.7

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.46

0.40

2.2

6.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

100

0.67

0.39

1.0

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

286

1.18

0.39

5.6

10.2

mmol/l

23.8

23.3

0.41

263

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.31

0.39

1.7

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

143

0.74

0.39

1.7

4.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

1.42

0.39

2.0

1.8

—

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.38

0.38

1.5

4.3

umol/l

123.7

265.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

278

2550

1.06

0.38

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

475

4729

0.95

0.37

2.9

2.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

110

0.70

0.37

2.0

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.30

0.37

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

226

0.81

0.36

2.3

4.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

388

1.15

0.36

2.4

2.8

ug/l

1.3

1.4

0.05

348

(21494434) Karyotype in Bone marrow

1.36

0.36

2.0

1.2

—

(3037121) Protein [Mass/volume] in Urine

483

0.87

0.35

5.1

6.4

g/l

0.2

0.5

2.01

330

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.34

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.31

0.33

1.0

1.1

—

(40768793) Breast Pathology biopsy report

140

1.24

0.33

1.1

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

538

1.11

0.33

1.3

—

(3002256) Pathology report gross observation

871

1.09

0.33

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

732

1.10

0.33

1.8

1.9

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.29

0.32

1.0

u/ml

22.3

34.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

750

0.91

0.32

1.5

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

185

1.20

0.32

1.3

u/ml

8.5

3.5

—

(3041354) Potassium [Moles/volume] in Venous blood

1.35

0.31

2.6

2.1

mmol/l

3.7

3.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.35

0.31

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

115

1.26

0.31

1.3

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

828

0.91

0.30

1.6

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

748

0.91

0.30

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

748

0.91

0.30

1.5

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

222

1.17

0.30

1.3

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

322

1.14

0.30

36.2

13.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

596

0.90

0.29

1.8

2.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

160

1.21

0.29

1.7

1.6

12.7

12.9

0.48

160

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

105

0.73

0.29

1.0

1.2

nmol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

125

1.24

0.29

3.1

2.2

—

(4268621)

125

1.24

0.29

2.1

2.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

745

0.91

0.29

1.5

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.23

0.29

1.0

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

724

6839

1.04

0.28

3.6

3.2

u/l

32.8

28.7

0.88

684

6536

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

301

0.86

0.28

1.2

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

145

0.80

0.27

1.8

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

115

0.75

0.27

9.8

10.9

mmol/l

0.6

—

109

(3019150) Specific gravity of Urine by Refractometry

275

2551

1.05

0.27

3.1

2.8

kg/l

1.0

1.02

394

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

322

2998

1.04

0.27

2.4

2.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.22

0.27

1.0

1.1

—

(4035726)

546

1.10

0.27

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

100

900

1.07

0.26

1.3

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

0.67

0.26

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

790

1.08

0.25

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.19

0.24

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.24

0.23

2.7

1.6

—

(3001556) Androgen free Index in Serum or Plasma

1.34

0.23

1.0

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.27

0.22

1.6

5.3

—

(3006653) Thiamine [Moles/volume] in Blood

1.27

0.22

1.2

1.3

nmol/l

139.0

134.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

103

1051

0.94

0.22

1.3

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.76

0.22

2.0

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

284

1.12

0.22

1.4

2.7

16.7

23.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

321

1.11

0.22

2.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.23

0.21

1.5

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

0.00

0.21

0.0

1.3

—

49.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

6.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.21

0.0

2.4

—

0.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

102

0.75

0.21

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.20

0.0

5.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.20

0.0

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

800

0.94

0.20

1.7

2.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.23

0.20

2.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.23

0.20

1.2

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

111

1016

1.06

0.20

3.7

5.1

ng/l

1573.0

933.5

0.31

805

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.20

0.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.20

0.0

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

0.20

0.0

1.1

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.20

0.0

4.6

—

139.1

—

(40763527) Lymphocytes.vacuolated [Presence] in Blood by Light microscopy

0.00

0.20

0.0

1.1

—

0.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.20

0.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.20

0.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

113

1.19

0.20

1.0

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

213

1.13

0.20

1.4

2.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

315

1.10

0.19

1.7

2.2

—

(3006462) Nitrate [Presence] in Urine

1.16

0.19

1.5

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.16

0.19

1.0

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

162

1622

0.96

0.19

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

343

1.10

0.19

23.7

14.3

mmol/l

23.9

23.8

0.06

331

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.22

0.18

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

187

1.13

0.18

2.2

3.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.20

0.18

1.0

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.76

0.17

5.8

6.9

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.76

0.17

5.8

6.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

179

1.13

0.17

1.3

u/ml

7.3

4.0

—

(3042733) HLA Ab [Presence] in Serum

0.73

0.17

5.0

3.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.72

0.17

1.4

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.19

0.16

2.1

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.17

0.16

2.9

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

257

0.90

0.16

1.5

1.9

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.12

0.16

1.4

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.10

0.16

1.3

1.5

108.4

93.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

116

1.16

0.15

2.3

1.9

111.3

111.5

0.01

111

(3024471) HLA-A [Type]

0.76

0.15

1.2

1.0

—

(3024932) HLA-DR beta [Type]

0.76

0.15

1.3

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.75

0.15

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

1.13

0.15

1.4

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

224

2100

1.03

0.15

1.5

—

(40768446) Kidney Pathology biopsy report

0.78

0.14

2.6

2.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.78

0.14

1.0

1.2

nmol/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

349

1.08

0.14

1.7

3.1

e6/l

34.1

10.1

0.46

260

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

349

1.08

0.14

1.8

3.1

e6/l

291.4

477.4

0.21

272

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

205

1923

1.03

0.14

1.7

1.6

1.4

1.3

0.30

188

1762

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

830

1.05

0.14

1.4

1.3

miu/ml

252.1

237.2

0.15

405

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

238

1.09

0.13

1.6

1.7

mmol/l

7.5

7.2

0.31

148

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

728

1.05

0.13

1.4

1.5

—

(4198724)

193

0.90

0.13

1.6

2.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

193

0.90

0.13

7.8

20.8

u/ml

0.3

0.17

120

(3035320) C reactive protein [Mass/volume] in Body fluid

109

1.15

0.13

2.8

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

295

1.08

0.12

1.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

784

0.96

0.12

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

452

4413

0.98

0.12

2.7

2.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

856

8181

1.02

0.11

3.0

2.8

mmol/l

2.7

0.59

806

7691

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

101

1.15

0.11

1.0

1.1

mg/l

260.8

287.5

0.86

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.15

0.11

1.0

1.2

—

(44790048)

240

0.92

0.10

1.4

2.3

—

(44806118)

240

0.92

0.10

1.4

2.3

—

(44790049)

239

0.93

0.09

1.4

2.3

—

(44790047)

239

0.93

0.09

1.4

2.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.07

0.09

1.0

1.1

—

(4211845)

1.11

0.09

1.5

2.0

—

(4034850)

215

1.08

0.09

7.0

5.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.07

0.08

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

119

0.89

0.08

11.1

10.4

mg/l

8.6

9.1

0.14

112

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

103

1.12

0.08

1.6

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

208

0.93

0.08

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.03

0.08

1.0

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

801

7763

0.99

0.08

2.9

2.6

mmol/l

1.2

1.1

1.09

759

7345

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

846

8100

1.01

0.08

2.9

2.7

mmol/l

1.4

4.33

797

7648

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.07

0.08

1.3

2.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.05

0.08

2.7

2.3

umol/l

17.2

16.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

862

1.03

0.08

14.4

10.9

mmol/l

1.3

1.4

0.18

797

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

0.80

0.07

1.0

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.09

0.07

2.1

1.7

—

981358.3

—

(40768795) Lymph node Pathology biopsy report

1.09

0.07

2.0

1.2

—

(3015183) Erythrocyte sedimentation rate

0.85

0.07

1.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.85

0.06

1.1

3.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.85

0.06

1.1

3.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

431

0.96

0.06

8.7

6.1

inr

1.3

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

366

3491

1.01

0.06

1.8

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

186

0.93

0.06

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.87

0.06

3.7

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.87

0.06

1.1

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.87

0.06

3.7

1.6

g/l

4.1

3.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.87

0.06

3.7

1.6

g/l

7.0

7.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

313

1.05

0.06

1.6

2.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

219

1.06

0.05

1.0

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

115

1.09

0.05

2.4

3.4

mmol/l

20.0

19.1

0.10

106

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

725

1.02

0.05

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

372

1.04

0.05

2.3

2.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

392

1.03

0.04

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

211

1.05

0.04

1.2

2.2

ug/l

0.6

0.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

145

1.06

0.03

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

134

0.93

0.03

1.2

1.3

promille

1.7

1.1

—

(1761868) Lipid panel - Serum or Plasma

320

3062

1.01

0.03

2.0

1.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

403

1.03

0.03

4.9

5.7

ng/l

105.7

176.3

1.13

354

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

120

1141

1.01

0.03

5.3

5.7

umol/l

8.9

6.0

0.60

105

952

(3008757) Leukocyte morphology finding [Identifier] in Blood

163

0.94

0.03

1.4

4.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.08

0.03

1.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

768

1.02

0.03

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

203

1.04

0.03

1.4

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

1.07

0.02

1.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

443

0.98

0.02

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

204

1.04

0.02

1.7

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

109

1.06

0.01

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

167

1.04

0.01

1.1

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

855

8241

1.00

0.00

3.0

2.8

mmol/l

4.4

4.5

1.28

810

7823

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

117

0.99

0.00

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

100

0.96

0.00

1.1

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

131

1.03

0.00

1.1

2.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

351

0.99

0.00

1.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.05

0.00

1.0

1.2

—

(3024928) Oxygen saturation in Venous blood

246

0.98

0.00

7.2

13.5

—

(3036489) Thrombin time

606

1.00

0.00

3.2

6.1

22.2

22.6

0.16

552

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

501

1.00

0.00

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

161

1.02

0.00

2.4

2.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3044941) Cell count panel - Synovial fluid

0.92

0.00

1.3

1.5

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.0

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.00

0.0

6.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

3.2

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

0.0

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

4.8

—

0.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

(40768800) Prostate Pathology biopsy report

0.00

0.0

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.93

0.00

3.2

5.0

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.0

1.2

—

2.3

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

379.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.0

2.0

—

442.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.89

0.00

1.2

1.4

g/l

0.7

0.9

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

1.01

0.00

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.91

0.00

3.7

1.6

g/l

2.8

3.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.93

0.00

1.2

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.94

0.00

1.6

1.3

126.3

99.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.94

0.00

7.6

7.9

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

0.00

0.0

1.0

—

65.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.93

0.00

1.2

1.3

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.4

—

247.8

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_FOODDERMAT and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_FOODDERMAT	1.166 [0.82, 1.66]	0.397
Birth year	0.994 [0.99, 1.0]	0.143

During the follow-up period (1.1.1998 — 31.12.2019), 67 out of 20631 females with L12_FOODDERMAT died.

Males

Parameter	HR [95% CI]	p-value
L12_FOODDERMAT	1.004 [0.79, 1.28]	0.975
Birth year	0.99 [0.98, 1.0]	0.035

During the follow-up period (1.1.1998 — 31.12.2019), 84 out of 27933 males with L12_FOODDERMAT died.

Mortality risk

Mortality risk for people of age

years, who have L12_FOODDERMAT.

N-year risk	Females	Males
1	0.097%	0.229%
5	0.584%	1.365%
10	1.745%	3.324%
15	3.17%	6.496%
20	5.573%	10.774%

Relationships between endpoints

↥

Index endpoint: L12_FOODDERMAT – Dermatitis due to ingested food

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dermatitis due to ingested food

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints